New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ovid Therapeutics Inc.
OVID
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

84M

Biotechnology

Next Earning date - 01 Nov 2024

84M

Biotechnology

Next Earning date - 01 Nov 2024

1.18USD
Shape-0.03 ( -2.48%)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

-65%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

71%

Quote Panel

Shape
Updated October 27, 2024
1W -0.84 % 1M 0.00 % 3M 12.38 % 1Y -66.38 %

Key Metrics

Shape
  • Market Cap

    83.75M


  • Shares Outstanding

    70.97M


  • Share in Float

    58.43M


  • Dividende

    0


  • Earning Date

    01 Nov 2024


  • Price Target

    1.18


  • Average Volume

    172887


  • Beta

    0.386


  • Range

    0.68-4.1


  • Industry

    Biotechnology


  • Website

    https://www.ovidrx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

147.56x

P/S Ratio

0.94x

P/B Ratio

0.0

Debt/Equity

-5241.5%

Net Margin

$-0.4

EPS

How OVID compares to sector?

P/E Ratio

Relative Strength

Shape

OVID

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

Shape2642%

2025-Revenue

$0.66

Shape-650%

2025-EPS

$1M

Shape94%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

downgrade

Previous: Outperform

2024-06-18

Now: Perform

B. Riley

initialise

Previous: Not converted

2024-04-30

Now: Buy

Wedbush

initialise

Previous: Not converted

2024-04-04

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.17
vs -0.17

Q4.22

arrow
arrow

N/A

-0.16
vs -0.38

Q1.23

arrow
arrow

N/A

-0.19
vs -0.23

Q2.23

arrow
arrow

N/A

-0.18
vs -0.21

Q3.23

arrow
arrow

N/A

-0.16
vs -0.17

Q4.23

arrow
arrow

N/A

-0.22
vs -0.16

Q1.24

arrow
arrow

N/A

-0.17
vs -0.19

Q2.24

arrow
arrow

+167%

0.12
vs -0.18

Q3.24

arrow
arrow

N/A

-0.21
vs -0.16

Q4.24

arrow
arrow

N/A

-0.19
vs -0.22

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

11.1K  vs NA

Q4.22

arrow
arrow

+100%

46.3K  vs -416348792

Q1.23

arrow
arrow

-95%

66.2K  vs 1.4M

Q2.23

arrow
arrow

NA

75K  vs NA

Q3.23

arrow
arrow

+882%

109K  vs 11.1K

Q4.23

arrow
arrow

+206%

141.6K  vs 46.3K

Q1.24

arrow
arrow

+124%

148K  vs 66.2K

Q2.24

arrow
arrow

+125%

169K  vs 75K

Q3.24

arrow
arrow

-3%

105.5K  vs 109K

Q4.24

arrow
arrow

-23%

108.6K  vs 141.6K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.10

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

+1259%

12.59
vs -0.09

Q2.23

arrow
arrow

-11%

-0.11
vs 12.59

Q3.23

arrow
arrow

-11%

-0.11
vs -0.11

Q4.23

arrow
arrow

-17%

-0.17
vs -0.11

Q1.24

arrow
arrow

-15%

-0.15
vs -0.17

Q2.24

arrow
arrow

+10%

0.1
vs -0.15

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

58

58
vs 56

4%

Q4.22

arrow
arrow

60

60
vs 58

3%

Q1.23

arrow
arrow

62

62
vs 60

3%

Q2.23

arrow
arrow

71

71
vs 62

15%

Q3.23

arrow
arrow

64

64
vs 71

-10%

Q4.23

arrow
arrow

77

77
vs 64

20%

Q1.24

arrow
arrow

81

81
vs 77

5%

Q2.24

arrow
arrow

74

74
vs 81

-9%

Earnings Growth

Latest News